You just read:

Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Phase 3 Trial in Uncontrolled Persistent Asthma

News provided by

Regeneron Pharmaceuticals, Inc.

Sep 11, 2017, 01:00 ET